Showing 6 posts of 6 posts found.


Basilea nominates Domenico Scala as new chairman

March 15, 2016
Business Services, Manufacturing and Production Basilea, Chariman, Executive appointment

Switzerland-based Basilea Pharmaceutica on Tuesday nominated Domenico Scala as the new chairman of the board. The current Chairman, Martin Nicklasson …

FDA approves new anti-fungal treatment

March 9, 2015
Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis

The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …


uniQure appoints Basilea’s chief commercial officer

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

GSK pays £146 million for eczema drug

June 13, 2012
Sales and Marketing Basilea, GSK, Stiefel, Toctino

GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …

Zeftera problems weigh down Basilea

February 5, 2010
Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …

Basilea buoyed by sales increase

September 1, 2009
Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

Latest content